P&K Skin Research Center Co. Ltd (347740) — Cash Flow Reinvestment Rate
P&K Skin Research Center Co. Ltd (347740) has a Cash Flow Reinvestment Rate of 0.72x as of September 2025, reinvesting ₩1.22 Billion (capex ₩281.11 Million plus investments ₩937.29 Million) from operating cash flow of ₩1.70 Billion. Check 347740 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
P&K Skin Research Center Co. Ltd Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for P&K Skin Research Center Co. Ltd across 7 annual periods. Explore 347740 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for P&K Skin Research Center Co. Ltd (2018–2024)
Year-by-year capital reinvestment analysis for P&K Skin Research Center Co. Ltd. For live market cap and broader valuation context, see P&K Skin Research Center Co. Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.05x | ₩9.50 Billion | ₩9.03 Billion | ₩622.12 Million | ▲ +130.4% |
| 2023 | 0.46x | ₩2.53 Billion | ₩5.55 Billion | ₩1.56 Billion | ▼ -39.7% |
| 2022 | 0.76x | ₩5.68 Billion | ₩7.51 Billion | ₩1.36 Billion | ▼ -53.9% |
| 2021 | 1.64x | ₩12.62 Billion | ₩7.70 Billion | ₩2.81 Billion | ▼ -62.1% |
| 2020 | 4.33x | ₩37.52 Billion | ₩8.67 Billion | ₩1.05 Billion | ▲ +631.7% |
| 2019 | 0.59x | ₩3.84 Billion | ₩6.49 Billion | ₩541.19 Million | ▲ +284.6% |
| 2018 | 0.15x | ₩655.80 Million | ₩4.26 Billion | ₩655.80 Million | — |